<h3>Meril has got ICMR approval for its self-use rapid antigen test for Covid-19, CoviFind. The test delivers results in 15 minutes, Meril said in a statement.</h3>
<p>Medtech firm Meril has said it has received approval from the Indian Council of Medical Research (ICMR) for its self-use rapid antigen test kit for Covid-19.</p>
<p>Meril&rsquo;s indigenous home-use rapid antigen test kits &ldquo;CoviFind&rdquo; will expand access to Covid-19 testing, while also helping the nation meet the demand for increased and frequent screening to curb the spread of the pandemic, Meril said in a statement.</p>
<p>The test delivers results swiftly, providing accurate results in 15 minutes, it added.</p>
<p>&ldquo;By making reliable rapid antigen testing available to all through a convenient format, Meril''s CoviFind test will facilitate early detection, isolation, treatment and contact tracing," Meril Senior Vice-President (Corporate Strategy) Sanjeev Bhatt said.</p>
<p>Meril said it has supplied a large number of tests across its Covid-19 diagnostics offerings across India, which include a multiplex RT-PCR test, Kavach antibody tests in partnership with ICMR.</p>
<h3><strong>What will the test include?</strong></h3>
<p>The test kit is equipped with testing materials including a test device, one sterile nasal swab and a pre-filled buffer tube with a cap and is priced at Rs 250 as an affordable single-pack, the company said.</p>

meril-gets-nod-from-icmr-for-its-indigenous-covid-19-self-test-kit